farnesol has been researched along with Fibrosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, J; Huang, C; Huang, H; Jing, X; Li, J; Li, Y; Liu, Q; Tang, Q; Xia, Y; Xu, Y; Yan, J; Zhang, G; Zhang, J; Zhang, T; Zhang, Z; Zhao, Y; Zhou, J | 1 |
| Aga-Mizrachi, S; Brunschwig, Z; Chapman, J; Dadush, O; Elad-Sfadia, G; Elbaz, M; Elmakayes, E; Ettinger, K; Haklai, R; Kloog, Y; Nevo, Y; Reif, S; Yanay, N | 1 |
2 other study(ies) available for farnesol and Fibrosis
| Article | Year |
|---|---|
Farnesylthiosalicylic Acid-Loaded Albumin Nanoparticle Alleviates Renal Fibrosis by Inhibiting Ras/Raf1/p38 Signaling Pathway.
Topics: Albumins; Animals; Farnesol; Fibrosis; Mice; Nanoparticles; Proto-Oncogene Proteins c-raf; Rats; Rats, Sprague-Dawley; Salicylates; Signal Transduction; Tissue Distribution | 2021 |
The Ras antagonist, farnesylthiosalicylic acid (FTS), decreases fibrosis and improves muscle strength in dy/dy mouse model of muscular dystrophy.
Topics: Animals; Base Sequence; Blotting, Western; Disease Models, Animal; DNA Primers; Farnesol; Fibrosis; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Muscle Strength; Muscular Dystrophies; ras Proteins; Salicylates | 2011 |